Baxter International Stock Forecast, Price & News

13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 6 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Baxter International stock.
View analyst ratings for Baxter International or view top-rated stocks.

Wall Street analysts have given Baxter International a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Baxter International wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Baxter International is scheduled to release its next quarterly earnings announcement on Thursday, July 29th 2021.
View our earnings forecast for Baxter International.

Baxter International will be holding an earnings conference call on Thursday, July 29th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Baxter International Inc. (NYSE:BAX) released its earnings results on Wednesday, April, 28th. The medical instruments supplier reported $0.76 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.64 by $0.12. The medical instruments supplier earned $2.95 billion during the quarter, compared to analyst estimates of $2.89 billion. Baxter International had a trailing twelve-month return on equity of 18.34% and a net margin of 9.04%. The firm's revenue for the quarter was up 5.1% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.82 earnings per share.
View Baxter International's earnings history.

Baxter International's stock was trading at $77.97 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, BAX shares have increased by 3.7% and is now trading at $80.82.
View which stocks have been most impacted by COVID-19.

Baxter International declared a quarterly dividend on Monday, May 3rd. Investors of record on Friday, June 4th will be given a dividend of $0.28 per share on Thursday, July 1st. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.39%. The ex-dividend date of this dividend is Thursday, June 3rd. This is an increase from Baxter International's previous quarterly dividend of $0.25.
View Baxter International's dividend history.

Baxter International pays an annual dividend of $1.12 per share and currently has a dividend yield of 1.38%. Baxter International has been increasing its dividend for 5 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio of Baxter International is 36.25%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Baxter International will have a dividend payout ratio of 27.72% next year. This indicates that Baxter International will be able to sustain or increase its dividend.
View Baxter International's dividend history.

Baxter International updated its FY 2021 earnings guidance on Thursday, May, 6th. The company provided earnings per share guidance of 3.470-3.550 for the period, compared to the Thomson Reuters consensus estimate of $3.400. The company issued revenue guidance of $12.61 billion-$12.72 billion, compared to the consensus revenue estimate of $12.53 billion.

13 brokers have issued 12 month price objectives for Baxter International's shares. Their forecasts range from $85.00 to $100.00. On average, they anticipate Baxter International's share price to reach $91.33 in the next twelve months. This suggests a possible upside of 13.0% from the stock's current price.
View analysts' price targets for Baxter International or view top-rated stocks among Wall Street analysts.

506 employees have rated Baxter International CEO José (Joe) Almeida on Glassdoor.com. José (Joe) Almeida has an approval rating of 85% among Baxter International's employees.

Some companies that are related to Baxter International include Abbott Laboratories (ABT), Medtronic (MDT), Intuitive Surgical (ISRG), Stryker (SYK), Becton, Dickinson and (BDX), Edwards Lifesciences (EW), Boston Scientific (BSX), IDEXX Laboratories (IDXX), DexCom (DXCM), ResMed (RMD), Insulet (PODD), Teleflex (TFX), STERIS (STE), Hologic (HOLX) and Abiomed (ABMD).
View all of BAX's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Baxter International investors own include CA (CA), Johnson & Johnson (JNJ), Pfizer (PFE), Cisco Systems (CSCO), Honeywell International (HON), Intel (INTC), Abbott Laboratories (ABT), The Procter & Gamble (PG), AT&T (T) and Verizon Communications (VZ).

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Baxter International's stock is owned by a variety of retail and institutional investors. Top institutional investors include Caisse DE Depot ET Placement DU Quebec (1.58%), Ameriprise Financial Inc. (1.52%), Geode Capital Management LLC (1.45%), Bank of New York Mellon Corp (0.88%), Putnam Investments LLC (0.64%) and New York State Common Retirement Fund (0.55%). Company insiders that own Baxter International stock include Albert P L Stroucken, Andrew Frye, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, Jeanne K Mason, John D Forsyth and Sean Martin.
View institutional ownership trends for Baxter International.

BAX stock was sold by a variety of institutional investors in the last quarter, including Ameriprise Financial Inc., Neuberger Berman Group LLC, Handelsbanken Fonder AB, Caisse DE Depot ET Placement DU Quebec, State of Tennessee Treasury Department, Mitsubishi UFJ Trust & Banking Corp, Martingale Asset Management L P, and Toronto Dominion Bank. Company insiders that have sold Baxter International company stock in the last year include Albert P L Stroucken, Andrew Frye, Giuseppe Accogli, James R Gavin III, and John D Forsyth.
View insider buying and selling activity for Baxter International or view top insider-selling stocks.

BAX stock was bought by a variety of institutional investors in the last quarter, including New York State Common Retirement Fund, Amundi Asset Management US Inc., BNP Paribas Arbitrage SA, Putnam Investments LLC, Geode Capital Management LLC, Quantitative Investment Management LLC, Dundas Partners LLP, and Hennion & Walsh Asset Management Inc..
View insider buying and selling activity for Baxter International or or view top insider-buying stocks.

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of BAX stock can currently be purchased for approximately $80.82.

Baxter International has a market capitalization of $40.64 billion and generates $11.67 billion in revenue each year. The medical instruments supplier earns $1.10 billion in net income (profit) each year or $3.09 on an earnings per share basis.

Baxter International employs 50,000 workers across the globe.

The following companies are subsidiares of Baxter International: ApaTech Limited, Baxter (China) Investment Co. Ltd, Baxter (Hellas) EPE, Baxter (India) Private Limited, Baxter AO, Baxter Belgium SPRL, Baxter Company Ltd, Baxter Corporation (Canada), Baxter Corporation Englewood, Baxter Deutschland GmbH, Baxter Distribution Center Europe SA, Baxter Healthcare (Guangzhou) Company Ltd, Baxter Healthcare (Shanghai) Company Ltd., Baxter Healthcare (Suzhou) Company Ltd, Baxter Healthcare (Thailand) Company Limited, Baxter Healthcare (Tianjin) Co. Ltd., Baxter Healthcare Corporation, Baxter Healthcare Limited, Baxter Healthcare Limited (Hong Kong China), Baxter Healthcare Limited (Taiwan), Baxter Healthcare Pty Ltd, Baxter Healthcare SA, Baxter Healthcare SA (Singapore Woodlands Branch), Baxter Healthcare Trading (Shanghai) Co. Ltd., Baxter Holding B.V., Baxter Hospitalar Ltda., Baxter Incorporated, Baxter Innovations & Business Solutions Private Limited (India), Baxter Limited, Baxter Manufacturing (Thailand) Co. Ltd., Baxter Medical AB, Baxter Oncology GmbH, Baxter Pharmaceutical Solutions LLC, Baxter Pharmaceuticals (Asia) Pte Ltd., Baxter Pharmaceuticals India Pvt Ltd., Baxter Polska Sp. z o.o., Baxter Productos Medicos Ltda., Baxter R and D Europe SPRL, Baxter S.A. de C.V., Baxter S.A.S., Baxter S.L., Baxter S.p.A., Baxter SA, Baxter Sales and Distribution LLC, Baxter Services Europe SA, Baxter Shared Services & Competencies Limited, Baxter de Guatemala Sociedad Anonima, Bieffe Medital S.p.A., Cheetah Medical, Cheetah Medical (Israel) Ltd., Cheetah Medical (UK) Limited, Cheetah Medical Inc., Gambro AB, Gambro Dasco S.p.A., Gambro Dialysatoren GmbH, Gambro Industries SAS, Gambro Lundia AB, Gambro Renal Products Inc., Laboratorios Baxter S.A., RTS Colombia SAS, Synovis Life Technologies Inc., and Synovis Micro Companies Alliance Inc..

Baxter International was founded in 1931.

The official website for Baxter International is www.baxter.com.

Baxter International is headquartered at One Baxter Parkway DF2-1W, Deerfield IL, 60015.

Baxter International's mailing address is One Baxter Parkway DF2-1W, Deerfield IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected]